GI
NVAX icon

Gradient Investments’s Novavax NVAX Stock Holding History

Gradient Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$6.33K – 958
2024
Q2 		$6.33K Hold
500
– – ﹤0.01% 819
2024
Q1 		$2.39K Sell
500
-1,848
-79% -$8.57K ﹤0.01% 820
2023
Q4 		$11.3K Hold
2,348
– – ﹤0.01% 814
2023
Q3 		$17K Sell
2,348
-165
-7% -$1.32K ﹤0.01% 704
2023
Q2 		$18.7K Sell
2,513
-219
-8% -$1.72K ﹤0.01% 702
2023
Q1 		$18.9K Buy
2,732
+384
+16% +$3.53K ﹤0.01% 691
2022
Q4 		$24.1K Hold
2,348
– – ﹤0.01% 659
2022
Q3 		$43K Hold
2,348
– – ﹤0.01% 505
2022
Q2 		$121K Buy
2,348
+1,100
+88% +$57K ﹤0.01% 351
2022
Q1 		$92K Sell
1,248
-78
-6% -$6.96K ﹤0.01% 380
2021
Q4 		$190K Buy
1,326
+174
+15% +$29.9K ﹤0.01% 283
2021
Q3 		$239K Buy
1,152
+58
+5% +$12.8K 0.01% 265
2021
Q2 		$232K Buy
1,094
+390
+55% +$71.5K 0.01% 264
2021
Q1 		$128K Buy
704
+504
+252% +$100K ﹤0.01% 328
2020
Q4 		$22K Hold
200
– – ﹤0.01% 550
2020
Q3 		$22K Buy
+200
New +$24.4K ﹤0.01% 553
2017
Q3 		– Sell
-33
Closed -$1K – 548
2017
Q2 		$1K Hold
33
– – ﹤0.01% 747
2017
Q1 		$1K Hold
33
– – ﹤0.01% 727
2016
Q4 		$1K Sell
33
-2,044
-98% -$59.6K ﹤0.01% 688
2016
Q3 		$86K Buy
+2,077
New +$268K 0.01% 222

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gradient Investments's NVAX Position: Q3 2024 in Review

Gradient Investments sold out of Novavax (NVAX) in Q3 2024, closing a stake of 500 shares — an estimated $6.33K sold.

Gradient Investments first reported a position in NVAX in Q3 2016 and held it in 20 quarters. The position peaked at $239K in Q3 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Gradient Investments reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 500 Novavax shares in Q3 2024, an estimated $6.33K.
  • Gradient Investments first reported a position in Novavax in Q3 2016 and held it in 20 quarters.
  • Gradient Investments's Novavax position peaked at $239K in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.